About Texas Cancer Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
1
CTI BioPharma
1
Case Comprehensive Cancer Center
1
NCIC Clinical Trials Group
1
Novacea
1
Theradex
1
Therion Biologics Corporation
1
Clinical Trials at Texas Cancer Care
During the past decade, Texas Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
1999-03-01
2001-11-01
Completed
4
Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
1999-10-01
Unknown status
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
2001-02-01
2005-01-01
Terminated
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
2001-01-01
Unknown status
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
2002-08-01
2005-12-01
Unknown status
250
PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
2004-06-01
Unknown status
250
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texas Cancer Care" #1 sponsor was "Amgen" with 1 trials, followed by "CTI BioPharma" with 1 trials
sponsored, "Case Comprehensive Cancer Center" with 1 trials sponsored, "NCIC Clinical Trials Group" with 1 trials sponsored and "Novacea"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Cancer Care"
#1 collaborator was "Aventis Pharmaceuticals" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Smith Kline Beecham" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Texas Cancer Care
According to Clinical.Site data, the most researched conditions in "Texas Cancer Care" are
"Lung Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Breast Cancer" (1 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Texas Cancer Care" in a lesser frequency.
Clinical Trials Intervention Types at Texas Cancer Care
Most popular intervention types in "Texas Cancer Care" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "docetaxel" (2 trials), "PANVAC™-VF" (1 trials), "arsenic trioxide" (1 trials), "calcitriol" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Cancer Care
The vast majority of trials in "Texas Cancer Care" are
5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Texas Cancer Care
Currently, there are NaN active trials in "Texas Cancer Care".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Texas Cancer Care,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Cancer Care, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".